Literature DB >> 20932954

Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.

Tao Yu1, Chunhong Liu, Pavel Belichenko, Steven J Clapcote, Shaomin Li, Annie Pao, Alexander Kleschevnikov, Allison R Bechard, Suhail Asrar, Rongqing Chen, Ni Fan, Zhenyu Zhou, Zhengping Jia, Chu Chen, John C Roder, Bin Liu, Antonio Baldini, William C Mobley, Y Eugene Yu.   

Abstract

As the genomic basis for Down syndrome (DS), human trisomy 21 is the most common genetic cause of intellectual disability in children and young people. The genomic regions on human chromosome 21 (Hsa21) are syntenic to three regions in the mouse genome, located on mouse chromosome 10 (Mmu10), Mmu16, and Mmu17. Recently, we have developed three new mouse models using chromosome engineering carrying the genotypes of Dp(10)1Yey/+, Dp(16)1Yey/+, or Dp(17)1Yey/+, which harbor a duplication spanning the entire Hsa21 syntenic region on Mmu10, Mmu16, or Mmu17, respectively. In this study, we analyzed the hippocampal long-term potentiation (LTP) and cognitive behaviors of these models. Our results show that, while the genotype of Dp(17)1Yey/+ results in abnormal hippocampal LTP, the genotype of Dp(16)1Yey/+ leads to both abnormal hippocampal LTP and impaired learning/memory. Therefore, these mutant mice can serve as powerful tools for further understanding the mechanism underlying cognitively relevant phenotypes associated with DS, particularly the impacts of different syntenic regions on these phenotypes.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20932954      PMCID: PMC3027718          DOI: 10.1016/j.brainres.2010.09.107

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

Review 2.  Long-term potentiation and memory.

Authors:  M A Lynch
Journal:  Physiol Rev       Date:  2004-01       Impact factor: 37.312

3.  Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice.

Authors:  Yanghong Meng; Yu Zhang; Vitali Tregoubov; Christopher Janus; Luis Cruz; Mike Jackson; Wei Yang Lu; John F MacDonald; Jay Y Wang; Douglas L Falls; Zhengping Jia
Journal:  Neuron       Date:  2002-07-03       Impact factor: 17.173

4.  Survey of embryonic stem cell line source strains in the water maze reveals superior reversal learning of 129S6/SvEvTac mice.

Authors:  Steven J Clapcote; John C Roder
Journal:  Behav Brain Res       Date:  2004-06-04       Impact factor: 3.332

5.  Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions.

Authors:  Terunaga Nakagawa; Kensuke Futai; Hilal A Lashuel; Irene Lo; Kenichi Okamoto; Thomas Walz; Yasunori Hayashi; Morgan Sheng
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

6.  The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function.

Authors:  J T Henderson; J Georgiou; Z Jia; J Robertson; S Elowe; J C Roder; T Pawson
Journal:  Neuron       Date:  2001-12-20       Impact factor: 17.173

7.  Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice.

Authors:  Andy N Mead; David N Stephens
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Angela J Villar; Charles J Epstein; Robert C Malenka; William C Mobley
Journal:  J Neurosci       Date:  2004-09-15       Impact factor: 6.167

9.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

Authors:  Pascal Kahlem; Marc Sultan; Ralf Herwig; Matthias Steinfath; Daniela Balzereit; Barbara Eppens; Nidhi G Saran; Mathew T Pletcher; Sarah T South; Gail Stetten; Hans Lehrach; Roger H Reeves; Marie-Laure Yaspo
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

10.  Synaptojanin 2 functions at an early step of clathrin-mediated endocytosis.

Authors:  Nicole Rusk; Phuong U Le; Stefania Mariggio; Ginette Guay; Cristiano Lurisci; Ivan R Nabi; Daniela Corda; Marc Symons
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

View more
  66 in total

1.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

2.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

3.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

Review 4.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

5.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Jessica Yu; Jeesun Kim; Larisa V Lysenko; Zheng Zeng; Y Eugene Yu; William C Mobley
Journal:  Neurobiol Dis       Date:  2017-03-22       Impact factor: 5.996

Review 6.  Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome.

Authors:  Xu-Qiao Chen; Mariko Sawa; William C Mobley
Journal:  Free Radic Biol Med       Date:  2017-10-12       Impact factor: 7.376

Review 7.  Mouse models for Down syndrome-associated developmental cognitive disabilities.

Authors:  Chunhong Liu; Pavel V Belichenko; Li Zhang; Dawei Fu; Alexander M Kleschevnikov; Antonio Baldini; Stylianos E Antonarakis; William C Mobley; Y Eugene Yu
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

8.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

9.  JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

Authors:  Kathryn D Tuttle; Katherine A Waugh; Paula Araya; Ross Minter; David J Orlicky; Michael Ludwig; Zdenek Andrysik; Matthew A Burchill; Beth A J Tamburini; Colin Sempeck; Keith Smith; Ross Granrath; Dayna Tracy; Jessica Baxter; Joaquin M Espinosa; Kelly D Sullivan
Journal:  Cell Rep       Date:  2020-11-17       Impact factor: 9.423

10.  Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.

Authors:  Kristi Clark; Lauren Sakowski; Karen Sperle; Linda Banser; Carlisle P Landel; Denise A Bessert; Robert P Skoff; Grace M Hobson
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.